Zebrafish as a platform to evaluate the potential of lipidic nanoemulsions for gene therapy in cancer.

Cascallar, María; Hurtado, Pablo; Lores, Saínza; Pensado-López, Alba; Quelle-Regaldie, Ana; Sánchez, Laura; Piñeiro, Roberto; de la Fuente, María.

Afiliação

Cascallar M; Nano-Oncology and Translational Therapeutics Group, Health Research Institute of Santiago de Compostela (IDIS), SERGAS, Santiago de Compostela, Spain.
Hurtado P; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain.
Lores S; Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain.
Pensado-López A; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain.
Quelle-Regaldie A; Roche-Chus Joint Unit, Translational Medical Oncology Group, Oncomet, Health Research Institute of Santiago de Compostela, Santiago de Compostela, Spain.
Sánchez L; Nano-Oncology and Translational Therapeutics Group, Health Research Institute of Santiago de Compostela (IDIS), SERGAS, Santiago de Compostela, Spain.
Piñeiro R; Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain.
de la Fuente M; Department of Zoology, Genetics and Physical Anthropology, Universidade de Santiago de Compostela, Campus de Lugo, Lugo, Spain.

Front Pharmacol ; 13: 1007018, 2022.

Article em En | MEDLINE | ID: mdl-36386231